Asset Publisher
COVID-19: Tests and medicine candidates developed in Vienna, Austria
COVID-19: Tests and medicine candidates in Austria in the Vienna region
Austria's life sciences sector is mobilizing against the SARS-CoV-2 pandemic. These efforts are part of the activities around the globe. In the new Highlights edition we introduce some products and product candidates from the Vienna region – the development of most of them has been facilitated with public funding.
Coronavirus diagnostics
-
Attoquant Diagnostics
-
EUCODIS Bioscience
-
Ingenetix
-
Lexogen
-
Technoclone
-
RT-LAMP test
-
Vienna COVID-19 Detection Initiative (VCDI)
Medicines in the pipeline
-
APEIRON Biologics
-
Apeptico
-
CEBINA
-
G.ST Antivirals
-
Marinomed
-
F4 Pharma
-
Panoptes
-
Polymun Scientific
-
Takeda
-
Themis Bioscience
-
Valneva
-
Viravaxx
Please find a more comprehensive overview online at the Life Science Platform LISAvienna
https://www.lisavienna.at/life-sciences-in-vienna/covid-19/